Paysign, Inc. (NASDAQ:PAYS – Get Free Report) major shareholder Daniel Spence sold 100,000 shares of the stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of $3.76, for a total transaction of $376,000.00. Following the transaction, the insider now directly owns 8,990,000 shares in the company, valued at approximately $33,802,400. This represents a 1.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.
Paysign Stock Performance
PAYS traded down $0.04 on Tuesday, reaching $2.48. 717,053 shares of the company’s stock were exchanged, compared to its average volume of 273,926. Paysign, Inc. has a twelve month low of $2.25 and a twelve month high of $5.59. The company’s 50 day moving average is $2.67 and its 200-day moving average is $3.25. The company has a market cap of $132.80 million, a price-to-earnings ratio of 16.53 and a beta of 0.93.
Paysign (NASDAQ:PAYS – Get Free Report) last released its quarterly earnings data on Tuesday, March 25th. The company reported $0.02 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.02. Paysign had a net margin of 14.28% and a return on equity of 30.64%. Sell-side analysts forecast that Paysign, Inc. will post 0.21 EPS for the current year.
Institutional Trading of Paysign
Analyst Ratings Changes
Separately, Lake Street Capital started coverage on Paysign in a research report on Friday, December 20th. They issued a “buy” rating and a $6.00 target price on the stock.
Read Our Latest Stock Report on PAYS
Paysign Company Profile
Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.
Recommended Stories
- Five stocks we like better than Paysign
- How to Calculate Stock Profit
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- Short Selling: How to Short a Stock
- NVIDIA Insiders Sell: This Is What It Means for the MarketĀ
- Health Care Stocks Explained: Why You Might Want to Invest
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Paysign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paysign and related companies with MarketBeat.com's FREE daily email newsletter.